Menu
GeneBe

PNPLA8

patatin like phospholipase domain containing 8, the group of Patatin like phospholipase domain containing

Basic information

Region (hg38): 7:108470416-108569666

Links

ENSG00000135241NCBI:50640OMIM:612123HGNC:28900Uniprot:Q9NP80AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial myopathy-lactic acidosis-deafness syndrome (Moderate), mode of inheritance: AR
  • mitochondrial myopathy-lactic acidosis-deafness syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitochondrial myopathy with lactic acidosisARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Musculoskeletal; Neurologic25512002

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PNPLA8 gene.

  • not provided (193 variants)
  • Inborn genetic diseases (62 variants)
  • Mitochondrial myopathy-lactic acidosis-deafness syndrome (18 variants)
  • not specified (3 variants)
  • PNPLA8-related condition (3 variants)
  • Abnormality of the musculature (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PNPLA8 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
49
clinvar
7
clinvar
56
missense
139
clinvar
4
clinvar
143
nonsense
3
clinvar
1
clinvar
1
clinvar
5
start loss
0
frameshift
5
clinvar
4
clinvar
9
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
2
1
3
non coding
4
clinvar
20
clinvar
4
clinvar
28
Total 8 5 145 73 11

Highest pathogenic variant AF is 0.0000263

Variants in PNPLA8

This is a list of pathogenic ClinVar variants found in the PNPLA8 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-108472444-T-C Uncertain significance (Oct 17, 2022)2179604
7-108472458-A-G Benign/Likely benign (Jan 29, 2024)782747
7-108472473-CAG-C Mitochondrial myopathy-lactic acidosis-deafness syndrome • not specified Conflicting classifications of pathogenicity (Jul 12, 2022)190128
7-108472481-T-A Uncertain significance (Jun 07, 2022)2003044
7-108472486-TCTTGA-T Pathogenic (Mar 21, 2023)2101064
7-108472494-T-C Likely benign (Sep 01, 2023)2877773
7-108472523-G-A Inborn genetic diseases Likely pathogenic (Dec 14, 2023)3216124
7-108472538-T-G Uncertain significance (Aug 09, 2022)2019800
7-108472551-T-C Likely benign (Dec 08, 2021)1553426
7-108472557-C-A Uncertain significance (Jul 12, 2022)1947543
7-108472583-G-A Pathogenic (Jul 07, 2023)2177027
7-108472589-C-T Mitochondrial myopathy-lactic acidosis-deafness syndrome Uncertain significance (Dec 17, 2018)870407
7-108472616-C-T Uncertain significance (Jun 27, 2022)1914241
7-108472618-G-A Uncertain significance (Jul 19, 2022)958787
7-108472629-A-G Likely benign (Aug 28, 2023)2732020
7-108472633-T-C Inborn genetic diseases Uncertain significance (Dec 14, 2021)2267073
7-108472640-C-T Inborn genetic diseases Uncertain significance (Sep 01, 2021)2247826
7-108472653-G-T Likely benign (Oct 07, 2022)1931685
7-108472680-T-C Likely benign (Jun 15, 2023)2868844
7-108472684-G-C Likely benign (Oct 17, 2022)742036
7-108472689-A-G Likely benign (Nov 13, 2023)1914338
7-108472689-A-T Likely benign (Jul 18, 2022)2060925
7-108479166-G-A Likely benign (Aug 29, 2023)1942127
7-108479173-A-G Likely benign (Aug 07, 2023)1908938
7-108479196-T-C Uncertain significance (May 13, 2022)1946678

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PNPLA8protein_codingprotein_codingENST00000422087 999245
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01100.9891257170231257400.0000915
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.09493954000.9870.00001995127
Missense in Polyphen6982.7150.834191135
Synonymous0.5741281370.9380.000006471461
Loss of Function3.771033.60.2970.00000182456

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005040.000491
Ashkenazi Jewish0.000.00
East Asian0.0001640.000163
Finnish0.0001390.000139
European (Non-Finnish)0.00006270.0000615
Middle Eastern0.0001640.000163
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Calcium-independent phospholipase A2, which catalyzes the hydrolysis of the sn-2 position of glycerophospholipids, PtdSer and to a lower extent PtdCho. Cleaves membrane phospholipids. {ECO:0000269|PubMed:10744668, ECO:0000269|PubMed:15695510}.;
Pathway
Eicosanoid Synthesis;Metabolism of lipids;Metabolism;phospholipases;Acyl chain remodelling of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Acyl chain remodelling of PE (Consensus)

Recessive Scores

pRec
0.105

Intolerance Scores

loftool
0.279
rvis_EVS
-0.42
rvis_percentile_EVS
25.79

Haploinsufficiency Scores

pHI
0.221
hipred
N
hipred_score
0.492
ghis
0.536

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.632

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pnpla8
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
prostaglandin biosynthetic process;fatty acid metabolic process;cell death;arachidonic acid metabolic process;phosphatidylcholine catabolic process;phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling;linoleic acid metabolic process;phosphatidylethanolamine catabolic process;arachidonic acid secretion
Cellular component
Golgi membrane;peroxisome;peroxisomal membrane;endoplasmic reticulum membrane;membrane;integral component of membrane;perinuclear region of cytoplasm
Molecular function
lysophospholipase activity;phospholipase A2 activity;ATP binding;calcium-independent phospholipase A2 activity